Iohexol plasma clearance in children: validation of multiple formulas and single-point sampling times

Camilla Tøndel1,2, Cathrin Lytomt Salvador3,4, Karl Ove Hufthammer5

  • 1Department of Pediatrics, Haukeland University Hospital, 5021, Bergen, Norway. camilla.tondel@helse-bergen.no.

Insights

The Fleming formula at 3 hours (GFR1p3h-Fleming) accurately estimates glomerular filtration rate (GFR) in children with CKD and GFR ≥ 30 mL/min/1.73 m2, offering a simpler alternative to two-point methods. For lower GFRs, multiple blood samples are recommended.

Area of Science:

  • Pediatric Nephrology
  • Diagnostic Imaging
  • Biomarker Analysis

Background:

  • Iohexol is a preferred non-ionic agent for glomerular filtration rate (GFR) measurement.
  • Accurate GFR estimation in children is challenging, necessitating methods that minimize blood draws.
  • This study evaluates single-time-point GFR formulas using iohexol clearance in pediatric chronic kidney disease (CKD).

Purpose of the Study:

  • To assess the accuracy of various single-point formulas for calculating measured GFR (mGFR) based on plasma iohexol clearance.
  • To identify the optimal blood sampling time point for single-point GFR estimation in children.
  • To compare single-point GFR methods with a reference multi-point method.

Main Methods:

  • A cross-sectional study involving 96 children with CKD stages 1-5.
  • Iohexol clearance measured with seven blood samples within 5 hours (GFR7p) served as the reference.
  • Six single-point GFR formulas were validated against the GFR7p reference.

Main Results:

  • The Fleming formula with a single blood draw at 3 hours (GFR1p3h-Fleming) demonstrated the best performance, with 82% of values within 10% of the reference (P10).
  • In children with GFR ≥ 30 mL/min/1.73 m2, GFR1p3h-Fleming achieved 92.3% P10, comparable to the two-point method (96.2%).
  • Significant variations in formula performance were observed across different CKD stages and sampling times.

Conclusions:

  • GFR1p3h-Fleming is recommended as a reliable single-point method for estimating mGFR in children with CKD and GFR ≥ 30 mL/min/1.73 m2.
  • For children with GFR < 30 mL/min/1.73 m2, slope-GFR using at least two blood samples is advised.
  • These findings support optimized GFR measurement protocols in pediatric nephrology.
Abstract

Related Concept Videos

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
385
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
939
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
285
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
421
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
280